Documentation of an instrument for assessment of subjective CNS-related symptoms during cardiovascular pharmacotherapy

Cardiovascular Drugs and Therapy
C G DahlöfB Olofsson

Abstract

The aim of this work was to develop and initiate the documentation of an instrument for the assessment of subjective CNS-related symptoms occurring during cardiovascular pharmacotherapy. The self-applied questionnaire developed for minor symptom evaluation (MSE profile) includes 24 items and uses a visual analogue scale to record symptoms. Three different studies were performed using a total of 86 healthy volunteers. Based on a subjective grouping followed by principal component analysis to confirm the grouping, three dimensions-contentment (eight items), vitality (five items), and sleep (three items)-were formed. The Cronbach's alpha coefficient, used to evaluate the internal consistency of these dimensions, was found to be 0.90, 0.88, and 0.85, respectively. To validate the MSE profile, the subjective symptoms of two classes of drugs with well-known symptom profiles, a nonselective, beta-blocker (propranolol) and a benzodiazepine (oxazepam), were compared in placebo-controlled randomized double-blind crossover studies. The obtained results indicate that the symptom profiles were different but were compatible with the previously reported effects of these compounds. It can be concluded that the MSE profile is practical, useful,...Continue Reading

References

Nov 1, 1977·Rheumatology and Rehabilitation·P J Scott, E C Huskisson
Jan 1, 1979·Scandinavian Journal of Psychology·L SjöbergL O Persson
Feb 1, 1979·Psychological Medicine·D P Goldberg, V F Hillier
Dec 1, 1979·International Journal of Epidemiology·T E KottkeJ T Salonen
Jan 1, 1978·Acta Medica Scandinavica·O AndersonL Wilhelmsen
Sep 25, 1975·The New England Journal of Medicine·L M Koran
Feb 1, 1985·British Journal of Clinical Pharmacology·R V LewisL E Ramsay
Aug 1, 1988·British Journal of Clinical Pharmacology·D CurrieN A Wright
Aug 1, 1988·British Journal of Clinical Pharmacology·A N NicholsonD G McDevitt
Apr 1, 1988·Archives of Internal Medicine·F M GengoP R Kinkel
Jun 26, 1986·The New England Journal of Medicine·S H CroogG H Williams
Jun 14, 1985·JAMA : the Journal of the American Medical Association·J D CurbW Williams
Aug 1, 1974·Journal of Chronic Diseases·C J BulpittS Carne
Feb 1, 1973·Psychological Medicine·R Kellner, B F Sheffield
Jan 1, 1974·Behavioral Science·L R DerogatisL Covi
Feb 1, 1983·Pharmacology, Biochemistry, and Behavior·A Bond, M Lader
Sep 1, 1984·British Journal of Clinical Pharmacology·R V LewisL E Ramsay
Jan 1, 1984·British Journal of Clinical Pharmacology·M J VandenburgW D Cooper
Jan 1, 1983·Clinical Pharmacology and Therapeutics·S A Salem, D G McDevitt
Dec 1, 1980·Journal of Epidemiology and Community Health·S M HuntE Papp
Jan 1, 1959·The British Journal of Medical Psychology·M HAMILTON

❮ Previous
Next ❯

Citations

Jan 1, 1990·European Journal of Clinical Pharmacology·E S DimenäsP W Lücker
Jan 1, 1991·European Journal of Clinical Pharmacology·M A WallanderI Wiklund
Dec 23, 2009·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Chris CameronScott Klarenbach
Feb 1, 1995·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·M L HelléniusU de Faire
Jun 1, 1990·Controlled Clinical Trials·I WiklundM Wahl
Jun 11, 2004·Clinical Cardiology·Stefan AgewallLoghman Henareh
Aug 1, 1993·Cephalalgia : an International Journal of Headache·C Dahlöf
Apr 1, 1993·Cephalalgia : an International Journal of Headache·C Dahlöf, R Björkman
Feb 9, 2010·Journal of Dental Research·N P Crofts-BarnesN M Girdler
Feb 1, 1995·Cephalalgia : an International Journal of Headache·C G Dahlöf, E Dimenäs
Oct 1, 1995·Cephalalgia : an International Journal of Headache·C G Dahlöf
Nov 6, 1998·Stroke; a Journal of Cerebral Circulation·S AgewallB Fagerberg
Jul 9, 2008·Coronary Artery Disease·Stefan Agewall, Loghman Henareh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.